Labor conditions of junior medical staff at oncological institutions and risks arising in the course of their work are considered in the present article.
Topicality. Monitoring of hygienic conditions of labor which was conducted at cancer oncological institutions of Ukraine has shown that 80-85% of junior medical staff’ work conditions do not correspond to requirements of occupational health and safety standards and refer to harmful and dangerous category of work.
That’s why research focused on health protection of junior medical staff during work with carcinogens as well as introduction of newest health and safety procedures into learning process are very actual and advanced.
Research statement. Most anticancer drugs that are used for oncology patients’ treatment have expressed non-selective, toxic effects on the body as well as mutagenic, carcinogenic influence. However, not only treated patient’s organism is affected by such exposure but junior medical staff that prepares, administrates and does utilization of drugs as well. That’s why this category of medical staff needs maximal protection. Also their work conditions require maximal control and correspondence to occupational safety rules.
Aim of the article. Introduction of questions related with occupational safety during work with anticancer drugs to the learning process of discipline “Occupational safety in the kind of business”. The main goal of this introduction is informing and teaching of further medical workers of procedures’ complex that form safety work conditions at the work with anticancer drugs.
Substantiation of necessity of introduction questions related to occupational safety during work with anticancer drugs in training program of junior medical staff with the aim of safety conditions arrangement.
World Health Organization (WHO) [Internet]. Available from: http://www.who.int/cancer/country-profiles/ru/.
Kundiiev YuI, Nahorna AM, Varyvonchyk DV. Professional cancer: epidemiology and prevention. Kiev: Education; 2008. 336 p.
Kundiiev Yu, Varyvonchyk D, Remennyk O. [Professional cancer: state and prospects of studying in Ukraine]. Oncology. 2010 March;3:224–228
Varyvonchyk D. [The development of a national system of prevention of occupational cancer in Ukraine]. Ukrainian Journal of the problems of Occupational Medicine. 2013 April;4:35–46
Varyvonchyk D, Shevchenko V, Edzhybiia O. [Medical and statistical features of cancer incidence health care workers Ukraine]. Health of the nation. 2015 February;2:32–36
Shevchenko V. [Evaluation of the production of carcinogenic hazard to health professionals when working with anticancer drugs]. Ukrainian Journal of the problems of Occupational Medicine. 2015 January;1:21–29
Tyulyandin S, Samoylenko I, Izmerova N, Kuzmina L. Manual for medical staff on safe handling of anticancer drugs. Kiev: Medicine; 2012. 472 p.
Connor TH, McDiarmid MA. Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings. CA: Cancer Journal for Clinicians. 2006;56:354–365. DOI: http://doi.org/10.3322/canjclin.56.6.354
Stewart B, Kleihues P. World Cancer Report. Medical oncology. Lyon: IARCPress; 2003 June. p. 281–291. Available from: https://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf .
Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H, Heederik D. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology. 2007 January;19 (1):112–119. DOI: http://doi.org/10.1097/01.ede.0000246827.44093.c1
Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars F, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg. 2000 July;44 (7):551–560. DOI: http://doi.org/10.1016/S0003-4878(00)00050-8.
Krstev S, Perunicic B, Vidakovic A. Work practice and some adverse health effects in nurses handling antineoplastic drugs. Med Lav. 2003 May;94(5):432–439
International Metalworkers’ Federation. Occupational cancer. Zero cancer: A union guide to prevention. 2007. http://www.bwint.org/pdfs/ZeroCanceENr.pdf.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.